MSD PD-1 inhibitor approved by the US FDA
我放心你带套猛
发表于 2024-1-14 10:06:13
329
0
0
On January 12th local time, Merck announced that the US Food and Drug Administration (FDA) has approved the use of Merck's PD-1 inhibitor Keytruda in combination with radiotherapy and chemotherapy (CRT) for the treatment of stage III-IVA cervical cancer patients defined by the International Federation of Obstetrics and Gynecology (FIGO) 2014.
LogoMoney.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表LogoMoney.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表LogoMoney.com立场，且不构成建议，请谨慎对待。
猜你喜欢
- Black Friday Quick Report: Online and offline online shopping in the United States is expected to set a new record!
- Delaware judge overturns Musk salary agreement, Tesla says it will appeal
- Merck PD-1 inhibitor pembrolizumab's fourth lung cancer indication approved in China
- Tesla surged last night! Bank of America raises Tesla's 12-month target price to $400 and maintains buy rating
- Weekly Outlook | US CPI may shake expectations of Fed interest rate cuts! Oracle and Broadcom announce their performance, will it affect the subsequent trend of AI concept stocks?
- Merck PD-1 inhibitor CRDA approved for the treatment of locally advanced cervical cancer in China
- Merck PD-1 inhibitor CRDA approved for the treatment of locally advanced cervical cancer in China
- Merck PD-1 inhibitor CRDA approved for the treatment of locally advanced cervical cancer in China
- The US warehouse strike poses challenges to Amazon's holiday shopping season operations
- Sanofi's BTK inhibitor is declared for market in China
-
美股市场：纽约股市三大股指4月30日涨跌不一。截至当天收盘，道琼斯工业平均指数比前一交易日上涨141.74点，收于40669.36点，涨幅为0.35%；标准普尔500种股票指数上涨8.23点，收于5569.06点，涨幅为0.15%；纳斯 ...- joey791216
- 8 小时前
- 支持
- 反对
- 回复
- 收藏
-
美国总统特朗普近日在接受媒体采访时表示，他第二个任期不仅治理美国，也治理全世界。 特朗普于4月24日接受了《大西洋》（The Atlantic）月刊采访，这段专访于4月28日发布。 “第一次当总统时，我要做两 ...- lfancn
- 昨天 12:10
- 支持
- 反对
- 回复
- 收藏
-
东风有限回应武汉工厂关停事宜 据第一财经，4月29日，东风汽车有限公司证实，该公司武汉工厂目前正常运行，后续也不会关停。东风有限称，该公司将在东风与日产母公司的支持下平稳有序发展，持续加速向新能源 ...- king19831101
- 昨天 09:56
- 支持
- 反对
- 回复
- 收藏
-
4月29日凌晨，阿里巴巴开源新一代通义千问模型Qwen3(千问3)，参数量为DeepSeek-R1的三分之一，成本大幅下降。据称，该模型性能全面超越R1、OpenAI-o1等领先模型，登顶全球最强开源模型。 千问3是国内首个“ ...- 风雨中行走
- 前天 10:32
- 支持
- 反对
- 回复
- 收藏
